Skip to main content
Skip to main content
OMRNY logo

OMRON Corporation (OMRNY)

$38.17 +$2.00 (+5.51%) |CouncilBUY · 56 · B
Bottom line: BUY — our Council read (56/100) and AI Score (54/100) broadly agree. Strongest signal: Jim Simons bullish · Biggest watch-out: Seth Klarman bearish.
MCap: $7.51B| P/E Ratio: 37.5| Vol: 300| Target: $45.58 (+19.4%)| 52-wk range: $23.23 – $40.76
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

OMRON Corporation (OMRNY) trades at $38.17 with AI Score 54/100 (Grade B). OMRON Corporation (OMRNY) is a global technology leader operating across industrial automation, electronic components, social infrastructure, and healthcare. Market cap: $7.51B, Sector: Technology.

Price live · AI analysis from Jun 14, 2026
OMRON Corporation (OMRNY) is a global technology leader operating across industrial automation, electronic components, social infrastructure, and healthcare. The company leverages its diverse portfolio to address market demands for efficiency, connectivity, and health management worldwide.

OMRNY stock analysis for 2026: Analysts have set a consensus price target of $45.58 for OMRON Corporation, suggesting 19.4% upside from the current price of $38.17. The AI MoonshotScore is 54/100, indicating a neutral outlook. Key factors: analyst coverage, AI-driven quantitative scoring.

Council Score · Weighted Average of 3 Disciplines
BUY 56/100 · B

OMRNY: 3/7 perspectives are bullish. Dominant signal: Jim Simons bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI
Ray Dalio
Bullish
Ken Griffin
Neutral
Jim Simons
Bullish
Izzy Englander
Neutral
Seth Klarman
Bearish
Moon AI
Bullish
Council Score · 8 perspectives · See tabs for details →

OMRON Corporation (OMRNY) Technology Profile & Competitive Position

CEOJunta Tsujinaga
Employees28450
HeadquartersKyoto, JP
IPO Year1996

OMRON Corporation (OMRNY) is a global technology leader, specializing in industrial automation, electronic components, social infrastructure systems, and healthcare devices. The Kyoto-based firm leverages its diverse portfolio to address demand for efficiency, connectivity, and health management across various global markets, supported by a long-standing history of innovation since 1933.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Jun 14, 2026

What Is the Investment Thesis for OMRNY?

OMRON Corporation (OMRNY) presents a diversified investment profile driven by its established leadership in industrial automation and growing presence in healthcare and social infrastructure. The company's robust Industrial Automation segment is well-positioned to capitalize on global trends towards factory automation, robotics, and smart manufacturing, supported by its comprehensive product portfolio. The Healthcare division benefits from an aging global population and increasing demand for remote monitoring and preventative care devices. OMRON's strategic partnership with JMDC Inc. for AI-driven health solutions could unlock new revenue streams by addressing personalized health management. Financially, OMRON maintains a gross margin of 45.7% and a profit margin of 3.7%, indicating operational efficiency. While its P/E ratio stands at 37.5, reflecting market expectations for future growth, the company also offers a dividend yield of 1.89%. Investors may want to evaluate the company's beta of 1.13, suggesting moderate volatility relative to the broader market, alongside potential liquidity risks associated with its OTC Other tier ADR status. Future performance hinges on its ability to innovate and adapt to technological shifts across its diverse segments.

Based on FMP financials and quantitative analysis

OMRNY Key Highlights

  • Market capitalization stands at $6.79 billion, reflecting OMRON's significant global presence in technology and automation.
  • Gross margin of 45.7% demonstrates strong cost management and pricing power across its diverse product lines.
  • Profit margin of 3.7% indicates the company's net profitability after all expenses, showcasing operational efficiency.
  • A P/E ratio of 37.5 suggests investor confidence in OMRON's future earnings growth potential, particularly in its high-tech segments.
  • OMRON offers a dividend yield of 1.89%, providing income for shareholders alongside potential capital appreciation.

Who Are OMRNY's Competitors?

OMRNY is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
GLW Corning Incorporated $199.56 +1.41% $171.75B 70
MRAAF Murata Manufacturing Co., Ltd. $64.38 -4.51% $117.19B 54
TTDKY TDK Corporation $21.78 -1.94% $41.34B 46
JBL Jabil Inc. $338.22 -0.90% $35.44B 65
FN Fabrinet $500.87 +0.25% $17.95B 49
MDA Macdonald Dettwiler & Associate $42.11 +3.34% 6B 66
WATT Energous Corporation $19.29 -19.93% $28.65M 65
SELX Selecta Biosciences, Inc. $0.34 +580.00% $12.78M 64

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are OMRNY's Key Strengths?

  • Broad and diversified product portfolio across industrial automation, healthcare, and social infrastructure.
  • Strong global brand recognition and established market presence since 1933.
  • Advanced technological capabilities and continuous innovation in sensing and control.
  • Strategic partnerships enhancing capabilities in emerging areas like AI-driven health.
  • High gross margin of 45.7% indicating efficient operations and pricing power.

What Are OMRNY's Weaknesses?

  • Profit margin of 3.7% could be susceptible to economic downturns or increased operational costs.
  • Reliance on global manufacturing trends for its industrial automation segment.
  • Exposure to currency fluctuations due to global operations and ADR status.
  • P/E ratio of 37.5 suggests a premium valuation, potentially limiting upside if growth expectations are not met.
  • Liquidity risks associated with trading on the OTC Other tier compared to major exchanges.

What Could Drive OMRNY Stock Higher?

  • Continued global investment in industrial automation infrastructure, driving demand for OMRON's robotics and control systems.
  • Expansion of healthcare product distribution channels and market penetration, particularly for remote monitoring devices.
  • Further development and adoption of AI-powered health solutions with JMDC Inc., potentially opening new recurring revenue streams.
  • Modernization efforts in social infrastructure globally, leading to increased demand for OMRON's PV inverters, railway, and traffic management systems.
  • Introduction of next-generation electronic and mechanical components addressing evolving technological requirements across industries.

What Are the Key Risks for OMRNY?

  • Global economic slowdown impacting industrial capital expenditure and consumer spending on healthcare devices.
  • Intense competition across all operating segments from both established global players and agile niche competitors.
  • Currency fluctuation exposure for ADR holders, as the value of the JPY relative to the USD directly affects returns.
  • Supply chain disruptions affecting component availability and manufacturing costs, impacting profitability.
  • Regulatory changes in the healthcare or industrial sectors that could impact product development, approval, or market access.

What Are the Growth Opportunities for OMRNY?

  • **Industrial Automation and Robotics Expansion:** The global industrial automation market is projected to continue its robust growth, driven by increasing labor costs, demand for higher productivity, and the ongoing digital transformation of manufacturing. OMRON, with its comprehensive suite of sensors, control devices, robotics, and automation systems, is well-positioned to capture a larger share of this market. The push towards Industry 4.0 and smart factories, which integrates IoT, AI, and advanced robotics, creates a sustained demand for OMRON's sophisticated solutions. This growth trajectory is expected to continue over the next decade as more industries adopt automation to enhance efficiency and competitiveness.
  • **Healthcare Technology and Preventative Care:** The healthcare sector is undergoing a significant transformation, with an increasing emphasis on preventative care, remote patient monitoring, and personalized health management. OMRON's strong portfolio of medical devices, including blood pressure monitors and body composition monitors, directly addresses these trends. The company's partnership with JMDC Inc. to develop customized solutions for preventing health deterioration and assisting with nursing care represents a strategic move into data-driven, predictive healthcare. This segment is poised for long-term growth as global populations age and healthcare systems seek more efficient and accessible solutions.
  • **Social Infrastructure Modernization and Green Energy:** OMRON's Social Systems, Solutions, and Service Business is strategically aligned with global initiatives for modernizing infrastructure and transitioning to green energy. The demand for photovoltaic (PV) inverters and energy storage batteries is surging as countries invest in renewable energy sources. Additionally, advanced railway station technologies, traffic management systems, and secure payment solutions are critical components of smart city development. These areas represent substantial, government-backed investment opportunities with long project timelines, providing stable revenue streams and growth potential for OMRON's integrated systems and software services.
  • **Advanced Electronic and Mechanical Components:** The continuous evolution of technology across various industries, including automotive, consumer electronics, and industrial equipment, fuels a consistent demand for high-quality electronic and mechanical components. OMRON's segment focused on relays, switches, connectors, and specialized sensors is critical to the supply chains of these sectors. As devices become more complex and miniaturized, the need for precise, reliable, and innovative components intensifies. OMRON's expertise in this area allows it to maintain a competitive edge by developing next-generation components that meet stringent performance and reliability requirements, ensuring ongoing relevance in a rapidly changing technological landscape.
  • **AI-Driven Health Solutions and Data Analytics:** The collaboration with JMDC Inc. to develop customized solutions for health deterioration prevention and nursing care represents a significant growth opportunity in the emerging field of AI-driven health analytics. By leveraging data to accurately predict individual health event risks and facilitate lifestyle changes, OMRON is moving beyond traditional medical device manufacturing into value-added digital health services. This initiative taps into the rapidly expanding market for health informatics and personalized medicine, offering a recurring revenue model potential and deeper integration into patient care pathways. The timeline for significant impact is likely medium to long-term as these solutions gain widespread adoption.

What Opportunities Does OMRNY Have?

  • Growing global demand for industrial automation, robotics, and smart factory solutions.
  • Expansion in the healthcare technology market driven by aging populations and remote monitoring trends.
  • Increased investment in smart cities, renewable energy, and modern social infrastructure worldwide.
  • Leveraging AI and data analytics through partnerships to create new value-added services in health.
  • Potential for market share gains through continuous product innovation and geographical expansion.

What Threats Does OMRNY Face?

  • Intense competition across all operating segments from both established players and new entrants.
  • Global economic slowdowns or recessions impacting capital expenditure in industrial and infrastructure sectors.
  • Disruptions in global supply chains affecting component availability and production costs.
  • Rapid technological obsolescence requiring significant R&D investment to maintain competitiveness.
  • Regulatory changes in healthcare or industrial standards impacting product development and market access.

What Are OMRNY's Competitive Advantages?

  • **Diversified Portfolio:** Broad product range across multiple critical sectors (industrial automation, healthcare, social infrastructure) reduces reliance on any single market.
  • **Established Brand and Reputation:** Nearly a century of operation (since 1933) has built a strong global brand recognized for quality and reliability in its core markets.
  • **Technological Expertise:** Deep R&D capabilities in sensing, control, robotics, and medical technology, leading to innovative product development.
  • **Global Presence:** Extensive sales and service networks worldwide, enabling broad market reach and customer support.
  • **Strategic Partnerships:** Collaborations like the one with JMDC Inc. enhance capabilities in emerging areas like AI-driven health solutions.

What Does OMRNY Do?

OMRON Corporation, trading under the symbol OMRNY, is a globally diversified technology company headquartered in Kyoto, Japan. Established in 1933 as OMRON Tateisi Electronics Co., the company officially rebranded to OMRON Corporation in January 1990, marking a significant evolution from its origins. OMRON operates through several core business segments: industrial automation, electronic and mechanical components, social infrastructure systems, and healthcare. The Industrial Automation division is a cornerstone of its operations, providing an extensive range of products including various sensors, switches, safety and control devices, relays, advanced automation systems, motion control solutions, robotics, and equipment for energy efficiency and power supplies, catering to the growing demand for smart factories and automated processes worldwide. The Electronic and Mechanical Components segment supplies critical parts such as relays, switches, connectors, and sensors, along with specialized components for the amusement industry, serving a broad array of manufacturing sectors. OMRON's Social Systems, Solutions, and Service Business is comprehensive, offering integrated systems like photovoltaic (PV) inverters, energy storage batteries, advanced railway station technologies including automated ticket gates, traffic management systems, secure payment solutions, and uninterruptible power supplies (UPS). This division also provides software development and maintenance services, underpinning essential social infrastructure. In the Healthcare sector, OMRON is a recognized manufacturer and distributor of medical devices, including blood pressure monitors, nebulizers, TENS electrotherapy units, digital thermometers, body composition monitors, activity trackers, and automated external defibrillators (AEDs). Demonstrating a commitment to innovation in health, OMRON Corporation has partnered with JMDC Inc. to develop customized solutions aimed at preventing health deterioration and assisting with nursing care, by leveraging data to predict individual health event risks and support lifestyle changes.

What Products and Services Does OMRNY Offer?

  • Manufactures and supplies industrial automation products like sensors, switches, robotics, and control systems.
  • Produces electronic and mechanical components such as relays, connectors, and specialized parts for various industries.
  • Develops and implements social infrastructure systems, including PV inverters, railway station technologies, and traffic management.
  • Provides secure payment solutions and uninterruptible power supplies (UPS) for critical infrastructure.
  • Designs and distributes healthcare devices, including blood pressure monitors, nebulizers, and digital thermometers.
  • Offers advanced health-related products like body composition monitors, activity trackers, and automated external defibrillators (AEDs).
  • Engages in software development and maintenance services for social infrastructure and transport management.
  • Partners to develop AI-driven solutions for health deterioration prevention and nursing care assistance.

How Does OMRNY Make Money?

  • Sells a wide range of industrial automation hardware and software solutions to manufacturing clients globally.
  • Generates revenue from the sale of electronic and mechanical components to original equipment manufacturers (OEMs) and other industrial clients.
  • Implements and maintains large-scale social infrastructure projects, including hardware, software, and service contracts.
  • Distributes medical devices directly to consumers and through healthcare providers, leveraging established brand recognition.
  • Engages in strategic partnerships, such as with JMDC Inc., to develop and potentially license or offer subscription-based health solutions.

What Industry Does OMRNY Operate In?

OMRON Corporation operates within the highly dynamic Technology sector, specifically in Hardware, Equipment & Parts, where it holds a significant position across multiple sub-industries. The company's industrial automation segment is a key player in the global smart manufacturing and robotics market, which is experiencing sustained growth driven by the need for increased efficiency, precision, and cost reduction in production processes. In the electronic and mechanical components space, OMRON competes within a fragmented but essential market, supplying critical parts for various industries. Its social infrastructure systems align with global trends in smart cities, renewable energy integration, and advanced transportation solutions. The healthcare division operates in a growing market for medical devices, propelled by demographic shifts, technological advancements in remote care, and a focus on preventative health. OMRON's diversified portfolio allows it to mitigate risks associated with single-market exposure and capitalize on interconnected technological advancements, positioning it against specialized competitors in each segment.

Who Are OMRNY's Key Customers?

  • Industrial manufacturers and factories seeking automation and efficiency solutions.
  • Original equipment manufacturers (OEMs) requiring electronic and mechanical components.
  • Government entities and public sector organizations for social infrastructure projects (e.g., railway, traffic management).
  • Healthcare providers, clinics, and hospitals utilizing medical devices.
  • Individual consumers purchasing health monitoring and wellness devices.
AI Confidence: 75% Updated: Jun 14, 2026

How OMRON Corporation Is Valued

OMRON Corporation carries a market capitalization of $7.51B, placing it in the mid-cap category. Relative to its peer group, OMRNY's quantitative score of 54/100 is roughly in line with the peer average of 57/100.

Company Profile

OMRON Corporation operates in the Hardware, Equipment & Parts industry within the Technology sector. It is headquartered in Kyoto, JP. The company is led by CEO Junta Tsujinaga. OMRNY has traded publicly since 1996.

ROE 4%Key Financial Metrics

Return on equity for OMRON Corporation stands at 3.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 1.9%, showing how much profit it generates from its asset base. OMRNY trades at a trailing price-to-earnings ratio of 37.45, roughly in line with the Technology sector average of ~38x. Its free cash flow yield is 0.7%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.83 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 2.4%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 7/9Financial Health

OMRON Corporation's Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 2.22 places it in the grey zone, a middle ground that warrants monitoring.

FY2026 estForward Outlook

Wall Street analysts project OMRON Corporation revenue of about $865.32B for fiscal 2026, with EPS near $165.72. The estimate reflects 5 contributing analysts.

OMRNY Financials

Fundamental Snapshot

Revenue Growth (FY)
+1.5%
Net Income Growth (FY)
+85.6%
EPS Growth (FY)
+85.6%
Free Cash Flow Growth (FY)
+22.0%
P/E (TTM)
41.4
Return on Equity (TTM)
+3.6%
Current Ratio
1.8
EV/EBITDA (TTM)
14.9

Based on FMP financials and quantitative analysis · FY 2026

Bull Case vs Bear Case

Bull Case

  • AI analysis temporarily unavailable
  • Check back shortly for updated insights
  • Market sentiment data being refreshed
  • Community discussions being analyzed

Bear Case

  • AI analysis temporarily unavailable
  • Check back shortly for updated insights
  • Risk factors being evaluated
  • Market concerns being processed

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

OMRNY Latest News

OMRNY Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for OMRNY.

Price Targets

Consensus target: $45.58

OMRNY MoonshotScore

54/100

What does this score mean?

The MoonshotScore rates OMRNY's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Junta Tsujinaga

CEO

Junta Tsujinaga serves as the CEO of OMRON Corporation, a global technology leader with 28,450 employees. His leadership is central to guiding the company's diverse operations across industrial automation, electronic components, social infrastructure, and healthcare. While specific details of his educational background and early career are not provided, his tenure as CEO of a multinational corporation of OMRON's scale implies extensive experience in global business management, strategic planning, and technological innovation within complex industrial and consumer markets.

Track Record: Under Junta Tsujinaga's leadership, OMRON Corporation continues to navigate a dynamic global landscape, focusing on strategic initiatives that enhance its market position. His tenure has seen the company maintain its established presence in industrial automation while expanding its footprint in high-growth areas like healthcare technology and social infrastructure solutions. Key strategic decisions likely include fostering innovation in robotics and AI-driven solutions, and overseeing partnerships such as the collaboration with JMDC Inc. to drive future growth and maintain OMRON's competitive edge in evolving markets.

OMRON Corporation ADR Information Unsponsored

OMRON Corporation (OMRNY) is traded as an American Depositary Receipt (ADR) Level 1. An ADR is a certificate issued by a U.S. depositary bank representing shares of a foreign company's stock. Level 1 ADRs are the most basic type, allowing foreign companies to trade on the U.S. OTC market without fully complying with SEC registration and reporting requirements. This makes OMRNY more accessible to U.S. investors who wish to invest in a Japanese company without directly trading on the Tokyo Stock Exchange.

  • Home Market Ticker: Tokyo Stock Exchange (TSE), Japan
  • ADR Level: 1
  • ADR Ratio: 1:1
  • Home Market Ticker: OMRN
Currency Risk: Investing in OMRNY, as an ADR, exposes U.S. investors to currency risk. The underlying shares are denominated in Japanese Yen (JPY), while the ADRs trade in U.S. Dollars (USD). Fluctuations in the JPY/USD exchange rate can impact the value of the investment, even if the underlying company's performance remains stable in JPY terms. A strengthening USD against the JPY would reduce the dollar value of OMRON's earnings and dividends when converted, potentially diminishing returns for U.S. investors, and vice versa.
Tax Implications: Dividends paid on OMRNY ADRs are subject to foreign dividend withholding tax by Japan. While the specific rate is not provided, investors typically face a withholding tax on dividends paid by Japanese companies. The actual tax rate can be influenced by tax treaties between the U.S. and Japan, which may reduce the statutory withholding rate. U.S. investors may be able to claim a foreign tax credit for these withheld taxes on their U.S. tax return, subject to IRS rules and limitations.
Trading Hours: OMRNY, as an ADR, trades during U.S. market hours on the OTC market. However, its underlying shares (OMRN) trade on the Tokyo Stock Exchange (TSE) during Japanese market hours. This time difference means that significant news or events occurring during Japanese trading hours may not be immediately reflected in the OMRNY price until U.S. markets open. Conversely, U.S. market activity can influence the ADR price, which may then impact the opening price of OMRN in Japan, creating potential arbitrage opportunities or price discrepancies.

OMRNY OTC Market Information

OMRNY trades on the OTC Other tier of the OTC market, which is distinct from major exchanges like the NYSE or NASDAQ. The OTC Other tier is the lowest of the OTC tiers, primarily for companies that do not meet the minimum financial or disclosure standards for OTCQX or OTCQB, or that choose not to provide current information. Unlike exchange-listed stocks, companies on OTC Other have minimal or unknown disclosure requirements, which can lead to less transparency regarding their financial health and operations. This tier is often associated with higher risk due to limited information and less regulatory oversight compared to higher tiers or major exchanges.

  • OTC Tier: OTC Other
  • Disclosure Status: Unknown
Liquidity: Trading OMRNY on the OTC Other tier typically implies lower liquidity compared to exchange-listed equities. Lower liquidity means fewer buyers and sellers, which can result in wider bid-ask spreads, making it more expensive to buy and sell shares. Investors may also experience difficulty executing large orders without significantly impacting the stock price. The trading volume can be inconsistent, leading to potential delays in transactions and increased price volatility. This reduced liquidity can make OMRNY a more challenging investment for institutional investors requiring efficient entry and exit points.
OTC Risk Factors:
  • **Limited Disclosure:** Unknown disclosure status means less readily available financial and operational information, hindering informed investment decisions.
  • **Lower Liquidity:** Trading on the OTC Other tier often results in lower trading volumes and wider bid-ask spreads, making it harder to buy or sell shares efficiently.
  • **Price Volatility:** Reduced liquidity and less transparency can contribute to higher price volatility, increasing investment risk.
  • **Regulatory Scrutiny:** Less stringent regulatory oversight compared to exchange-listed stocks may expose investors to greater risks.
  • **Information Asymmetry:** The potential for information asymmetry between insiders and public investors due to less comprehensive public reporting.
Due Diligence Checklist:
  • Verify the company's official filings with its home country regulator (e.g., Japan's financial services agency) if available.
  • Research the company's business fundamentals, including its global market position, product innovation, and competitive landscape.
  • Analyze the underlying home market stock (OMRN) performance and trading activity for insights into its primary valuation.
  • Assess the impact of currency fluctuations between JPY and USD on the ADR's value and dividend payouts.
  • Evaluate the company's long-term growth strategies and how they align with global industrial and healthcare trends.
  • Examine the company's dividend history and policy, considering foreign withholding taxes.
  • Monitor news and press releases from the company's home country for timely updates.
Legitimacy Signals:
  • **Long Operating History:** Established in 1933, OMRON Corporation has a nearly century-long track record of operations.
  • **Global Presence:** Operates on a global scale with diverse business segments in industrial automation, healthcare, and social infrastructure.
  • **Significant Employee Base:** Employs 28,450 individuals, indicating a substantial and established organization.
  • **Diversified Revenue Streams:** Engages in multiple, distinct business areas, reducing reliance on a single market.
  • **Strategic Partnerships:** Collaboration with entities like JMDC Inc. demonstrates ongoing innovation and market relevance.

OMRON Corporation Technology Stock: Key Questions Answered

What does OMRON Corporation do?

OMRON Corporation is a diversified global technology company with headquarters in Kyoto, Japan. It operates across four primary business segments: industrial automation, electronic and mechanical components, social infrastructure systems, and healthcare. In industrial automation, OMRON provides a wide array of products including sensors, robotics, and control systems for factories. Its electronic components segment supplies critical parts like relays and switches. The social infrastructure division offers solutions such as PV inverters, railway systems, and traffic management. In healthcare, OMRON manufactures medical devices like blood pressure monitors and nebulizers. The company also engages in software development and strategic partnerships for AI-driven health solutions, leveraging its long history since 1933 to serve diverse global markets.

How does OMRON Corporation generate revenue from its technology products?

OMRON Corporation generates revenue through the sale of a broad portfolio of technology products and integrated solutions across its segments. In industrial automation, revenue primarily comes from selling hardware like sensors, control devices, and robotics, alongside associated software and systems integration services to manufacturers. The electronic and mechanical components segment earns revenue by supplying essential parts to various industries. Its social infrastructure business secures revenue from large-scale project implementations, including the sale of PV inverters, railway systems, payment solutions, and ongoing maintenance contracts. In the healthcare sector, revenue is derived from the direct sale of medical devices to consumers and through distribution channels to healthcare providers. Additionally, emerging partnerships in AI-driven health solutions could introduce new service-based or licensing revenue streams.

What is OMRON Corporation's competitive position in the tech sector?

OMRON Corporation holds a robust competitive position in the tech sector due to its extensive diversification, long-standing brand reputation, and continuous innovation. In industrial automation, it competes as a global leader with a comprehensive product range that offers integrated solutions for smart factories, differentiating itself through advanced sensing and control technologies. In electronic components, its quality and reliability are key competitive advantages. The company's healthcare division benefits from strong brand recognition in medical devices. OMRON's ability to cross-leverage technologies and expertise across its segments, coupled with strategic partnerships like the one with JMDC Inc. for AI-driven health, allows it to maintain relevance and adapt to evolving market demands, positioning it against specialized competitors in each of its diverse markets.

What are the main risks for OMRNY?

OMRNY faces several key risks, including its exposure to global economic cycles, which can impact industrial capital expenditure and consumer spending on healthcare devices. The company operates in highly competitive markets across all its segments, requiring continuous innovation and investment to maintain market share. As an American Depositary Receipt (ADR) traded on the OTC Other tier, OMRNY carries specific risks related to currency fluctuations between the Japanese Yen and the U.S. Dollar, which can affect investor returns. Furthermore, the OTC Other tier implies lower liquidity, wider bid-ask spreads, and potentially less transparent financial disclosure compared to exchange-listed stocks, making due diligence more challenging and increasing investment risk. Supply chain disruptions and rapid technological obsolescence also pose ongoing threats to its operations and profitability.

What are the key factors to evaluate for OMRNY?

OMRON Corporation (OMRNY) holds an AI score of 54/100 (moderate). P/E: 37.5x vs the S&P 500's ~20-25x. Analysts target $45.58 (+19%). Not financial advice.

How frequently does OMRNY data refresh on this page?

OMRNY prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven OMRNY's recent stock price performance?

OMRON Corporation (OMRNY) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Broad and diversified product portfolio across industrial automation, healthcare, and social infrastructure. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider OMRNY overvalued or undervalued right now?

OMRON Corporation (OMRNY) trades at 37.5x earnings. Analysts target $45.58 (+19%) — upside seen. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Data Sources

Popular Stocks